Treatment Failure, Drug Resistance, and CD4 T-Cell Count Decline Among Postpartum Women on Antiretroviral Therapy in South Africa
Authors:
- Christopher J. HoffmannCHChristopher J. Hoffmann
- Silvia CohnSCSilvia Cohn
- Fildah Bsn MashabelaFMFildah Bsn Mashabela
- Jennifer D. Mph HoffmannJHJennifer D. Mph Hoffmann
- Helen McIlleronHMHelen McIlleron
- Paolo DentiPDPaolo Denti
- David W. HaasDHDavid W. Haas
- Kelly E. DooleyKDKelly E. Dooley
- Neil A. Mbbch MartinsonNMNeil A. Mbbch Martinson
- Richard E. ChaissonRCRichard E. Chaisson
- 1 January 2016
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 71 (1) , 31-37
Abstract
Background: We assessed HIV RNA suppression, resistance, and CD4 T-cell count 12 months postpartum among pregnant women retained in care in an observational cohort study. Methods: We prospectively followed two groups of HIV-infected pregnant women—with or without tuberculosis—recruited from prenatal clinics in South Africa. Women who received antiretroviral therapy during pregnancy and reported being on therapy 12 months postpartum were included. Serum samples from women with HIV viremia 12 months postpartum were tested for drug resistance. Results: Of 103 women in the study, median age and CD4 T-cell count at enrollment were 29 years [interquartile range (IQR): 26–32] and 317 cells per cubic millimeter (IQR: 218–385), respectively; 43 (42%) had tuberculosis at baseline. During pregnancy, 87% of the women achieved an HIV RNA P < 0.001). Factors independently associated with an HIV RNA <400 copies per milliliter at 12 months were age ≥30 years, detectable plasma efavirenz concentration, and HIV RNA <400 copies per milliliter while pregnant; there was a trend toward both a detectable viral load and peripartum depression. HIV drug resistance results were available from 25 women, and 12 (48%) had major drug resistance mutations. CD4 T-cell count declined a median of 13 cells per cubic millimeter (IQR: −66 to 140) from delivery to 12 months in women with viremia at 12 months. Conclusions: Success with maintaining virologic control declined postpartum among HIV-infected women who remained in care and on antiretroviral therapy, and CD4 T-cell count decline and drug resistance were common.Keywords
This publication has 42 references indexed in Scilit:
- Low Primary and Secondary HIV Drug-Resistance after 12 Months of Antiretroviral Therapy in Human Immune-Deficiency Virus Type 1 (HIV-1)-Infected Individuals from Kigali, RwandaPLOS ONE, 2013
- Reasons for poor adherence to antiretroviral therapy postnatally in HIV-1 infected women treated for their own health: experiences from the Mitra Plus study in TanzaniaBMC Public Health, 2013
- Life Expectancies of South African Adults Starting Antiretroviral Treatment: Collaborative Analysis of Cohort StudiesPLOS Medicine, 2013
- HIV Development Assistance and Adult Mortality in AfricaJAMA, 2012
- Viremia, Resuppression, and Time to Resistance in Human Immunodeficiency Virus (HIV) Subtype C during First‐Line Antiretroviral Therapy in South AfricaClinical Infectious Diseases, 2009
- Associations betweenCYP2B6Polymorphisms and Pharmacokinetics after a Single Dose of Nevirapine or Efavirenz in African AmericansThe Journal of Infectious Diseases, 2009
- Loss to follow-up and mortality among pregnant women referred to a community clinic for antiretroviral treatmentAIDS, 2008
- Prevalence of HIV‐1 Drug Resistance after Failure of a First Highly Active Antiretroviral Therapy Regimen in KwaZulu Natal, South AfricaClinical Infectious Diseases, 2008
- What is the relevance of mental health to HIV/AIDS care and treatment programs in developing countries? A systematic reviewAIDS, 2006
- Detection of Postnatal DepressionThe British Journal of Psychiatry, 1987